Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$15.22B
-52.98
82.80%
3 Buy
0 Hold
0 Sell
Strong Buy
Simcere Pharmaceutical Group Limited
HK$12.77
HK$33.15B
33.08
90.88%
3 Buy
0 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.14
HK$9.55B
-45.65
95.44%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.10
HK$8.73B
-15.19
79.98%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$13.92B
97.36
315.15%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
54.20
24.15
80.37%
HK:1672
Ascletis Pharma, Inc.
12.61
9.60
318.94%
HK:2096
Simcere Pharmaceutical Group Limited
12.77
6.08
90.88%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.14
2.55
98.46%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.10
6.07
67.22%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
35.08
26.68
317.62%